Philadelphia, PA
Announcements regarding the safety and efficacy results of ongoing studies are of great interest to the stakeholders of your organization and it is essential that the counterparts of your clinical research teams collaborate to effectively disseminate this sensitive material.
The 2nd Interim Analysis Symposium will provide drug safety and clinical operations teams with best practices and tried-and-true strategies that will enhance the capacity at which organizations can produce upstanding reports about the results of their ongoing studies and expedite effective products to market.
Don’t miss out on this opportunity to consult with and learn from industry experts during interactive panel discussions, advanced case studies, engaged roundtables and peer networking breaks.
